e_image":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/897ae7fe-bbc0-4162-dccf-200617d05700/public","additional_info":null,"target_audience":"

Medical oncologists and hematologists
Medical oncology and hematology fellows
Oncology nurses
Nurse practitioners
Physician assistants
Pharmacists

","meta_description":"","calculated_credit":null,"learning_objectives":"

Review strategies for initial therapy and therapies for relapsed disease for patients with various hematologic malignancies
Outline efficacy and toxicities of small molecule inhibitors, monoclonal antibodies, antibody drug conjugates, T-cell redirecting bispecific antibodies, and CAR-T for the treatment of patients with hematologic malignancies
Apply an individualized treatment plan for patients with ALL, AML, CML, MPN, MM, NHL, HL, based on patient- and disease-related factors
Review evolving role of autologous and allogeneic stem cell transplantation in different hematologic malignancies

","organizing_committee":"

Conference Chairs:

Carolyn Mulroney, MD - Sarah Cannon Transplant & Cellular Therapy Program at MountainView Hospital
Brian Vicuna, MD - Summerlin Hospital Medical Center / Comprehensive Cancer Centers
Edwin Kingsley, MD - Comprehensive Cancer Centers

Planning Committee Members:

Navneet Majhail, MD, MS, FASTCT - Sarah Cannon

","price_additional_info":null,"accreditation_additonal_info":null},"programData":[{"id":1754504120124,"title":"Treatment of Low Grade MDS","start":"2025-10-18T16:00:00.000Z","end":"2025-10-18T16:15:00.000Z","description":null,"raw_faculty":[{"id":7,"role":"faculty","uuid":"e342b71f-8a31-416c-bb80-5113d31a4aa3","conf_id":19,"faculty":{"id":952,"bio":"I am an academic clinical researcher at City of Hope National Medical Center in the department of hematology and hematopoietic cell transplantation. I completed my medical school training at Georgetown, internal medicine residency at Yale and Hematology/Oncology Fellowship and Memorial Sloan Kettering Cancer Center. My research focuses on the development of personalized therapies to improve outcomes for patients with myeloid malignancies and to prevent relapse after allogeneic stem cell transplant. I am interested in determining molecular biomarkers of response and resistance to myelodysplastic syndrome and acute myeloid leukemia therapies. I also develop and lead clinical trials evaluating therapies and combinations targeting molecularly defined subgroups. ","dob":null,"city":"Arcadia","uuid":"e342b71f-8a31-416c-bb80-5113d31a4aa3","email":"brball@coh.org","state":"CA","prefix":"Dr.","street":"2211 Canyon Road","country":"United States","zipcode":"91006","isActive":true,"latitude":null,"pronouns":null,"last_name":"Ball","longitude":null,"work_city":null,"additional":null,"created_at":"2025-08-05T20:33:55.38673+00:00","first_name":"Brian","updated_at":"2025-08-06T18:16:03.493542+00:00","work_state":null,"abim_number":null,"customer_id":2388,"middle_name":null,"nabp_number":null,"work_street":null,"designations":[{"id":3499,"isActive":true,"created_at":"2025-08-18T11:41:55.569825+00:00","customer_id":null,"designation":{"id":16,"title":"MD","isActive":true,"created_at":"

Conferences

Conference Summary:

Target Audience:

Organizing Committee:

Learning Objectives: